Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arash Mostaghimi

Showing results (281-290 of 339) with videos related to

Pageof 34
Sort By:
Archives of Dermatological Research|April 18, 2024
Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative studyAlice J Tan, Marjorie Archila, John S Barbieri, et al.
American Journal of Clinical Dermatology|April 11, 2025
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of TreatmentBrett King, Arash Mostaghimi, Yutaka Shimomura, et al.
JAMA Dermatology|January 21, 2026
Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine InhibitorMaria C Schneeweiss, Richard Wyss, Priyanka Anand, et al.
JAMA Dermatology|February 21, 2019
Clinical Features and Comorbidities of Patients With Necrobiosis Lipoidica With or Without DiabetesDavid A Hashemi, Zoe O Brown-Joel, Elizabeth Tkachenko, et al.
JAAD International|January 23, 2023
Factors influencing alopecia areata treatment decisions: A qualitative assessmentJane J Han, Adam Faletsky, Shilpa Ghatnekar, et al.
Journal of the American Academy of Dermatology|December 17, 2022
Monkeypox outbreak, vaccination, and treatment implications for the dermatologic patient: Review and interim guidance from the Medical Dermatology SocietyAnusha M Kumar, Steven T Chen, Joseph F Merola, et al.
Journal of the American Academy of Dermatology|May 1, 2026
Initial development and pragmatic clinical validation of a static disease severity instrument for pyoderma gangrenosum: Investigator Global Assessment for PG (IGAPg)Michael E Jacobson, Justin W Ng, Laura Morales Leon, et al.
Journal of the American Academy of Dermatology|June 9, 2024
Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studiesArash Mostaghimi, Justin Ko, Antonella Tosti, et al.
JAMA Dermatology|April 13, 2022
Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint InhibitorsJordan T Said, Mofei Liu, Jordan Talia, et al.
Journal of the American Academy of Dermatology|March 20, 2021
Development and validation of the Brigham Eyelash Tool for Alopecia (BELA): A measure of eyelash alopecia areataPriya Manjaly, Sara J Li, Elizabeth Tkachenko, et al.
Pageof 34

Showing results (281-290 of 339) with videos related to

Sort By:
Pageof 34
Archives of Dermatological Research|April 18, 2024
Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative studyAlice J Tan, Marjorie Archila, John S Barbieri, et al.
American Journal of Clinical Dermatology|April 11, 2025
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of TreatmentBrett King, Arash Mostaghimi, Yutaka Shimomura, et al.
JAMA Dermatology|January 21, 2026
Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine InhibitorMaria C Schneeweiss, Richard Wyss, Priyanka Anand, et al.
JAMA Dermatology|February 21, 2019
Clinical Features and Comorbidities of Patients With Necrobiosis Lipoidica With or Without DiabetesDavid A Hashemi, Zoe O Brown-Joel, Elizabeth Tkachenko, et al.
JAAD International|January 23, 2023
Factors influencing alopecia areata treatment decisions: A qualitative assessmentJane J Han, Adam Faletsky, Shilpa Ghatnekar, et al.
Journal of the American Academy of Dermatology|December 17, 2022
Monkeypox outbreak, vaccination, and treatment implications for the dermatologic patient: Review and interim guidance from the Medical Dermatology SocietyAnusha M Kumar, Steven T Chen, Joseph F Merola, et al.
Journal of the American Academy of Dermatology|May 1, 2026
Initial development and pragmatic clinical validation of a static disease severity instrument for pyoderma gangrenosum: Investigator Global Assessment for PG (IGAPg)Michael E Jacobson, Justin W Ng, Laura Morales Leon, et al.
Journal of the American Academy of Dermatology|June 9, 2024
Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studiesArash Mostaghimi, Justin Ko, Antonella Tosti, et al.
JAMA Dermatology|April 13, 2022
Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint InhibitorsJordan T Said, Mofei Liu, Jordan Talia, et al.
Journal of the American Academy of Dermatology|March 20, 2021
Development and validation of the Brigham Eyelash Tool for Alopecia (BELA): A measure of eyelash alopecia areataPriya Manjaly, Sara J Li, Elizabeth Tkachenko, et al.
Pageof 34